Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

31. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 11723


	Articles 1 - 20 / 234450

	Gut microbiota reshaping the pancreatic cancer immune microenvironment: new avenues for immunotherapy. Mol Cancer Zheng SH, Li KZ, Feng G, Wang YT, Wang JN, Li SQ, Sun YD. PMID: 41469665 [PubMed - indexed for MEDLINE]
	Multidimensional regulatory roles and therapeutic applications of SRSF7 in cancer. Cell Death Discov Li Y, Gao H, Zhang X, Sun F, Guo Y, Qiao X. PMID: 41469394 [PubMed - as supplied by publisher]
	Impact of a recent cancer diagnosis on bleeding risk after myocardial infarction. Heart Ow KW, Tyrer F, Van Den Berg F, Lai J, Vernon S, Paley L, Wenzl FA, Weston C, Rutherford MJ, Lambert PC, de Belder MA, Deanfield J, Peake MD, Adlam D. PMID: 41469213 [PubMed - as supplied by publisher]
	Duodenal metastases from lung adenocarcinoma causing gastrointestinal bleeding: a rare aetiology. BMJ Case Rep Rahim N, Méndez G, Sonawane SS, Shuja A. PMID: 41469173 [PubMed - indexed for MEDLINE]
	Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer. J Nucl Med Rong Z, Liu H, Teng X, Chen L, Gu Y, Dong B, Duan X, Wang X, Pang X. PMID: 41469159 [PubMed - as supplied by publisher]
	Prediction of the Clinicopathological Prognosis of Colon Cancer After Radical Resection Using Artificial Intelligence "TabNet". Anticancer Res Kosuge T, Mazaki J, Kasahara K, Osakabe H, Kuwabara H, Iwasaki K, Oguma J, Koga H, Kanazawa A, Nagakawa Y. PMID: 41469119 [PubMed - indexed for MEDLINE]
	Association of Matrix Metalloproteinase-11 Genotypes With Taiwan Gastric Cancer Risk and Clinical Features. Anticancer Res Fu CK, Tsai CW, Mong MC, Lee HT, Yang MD, Hsu CL, Hsia TC, Yueh TC, Bau DT, Chang WS. PMID: 41469118 [PubMed - indexed for MEDLINE]
	Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study. Anticancer Res Narihiro S, Kitaguchi D, Ryu S, Fukuda M, Kamada T, Nakashima S, Kumamoto T, Toya N, Eto K. PMID: 41469105 [PubMed - indexed for MEDLINE]
	Immune Microenvironment Signatures Predict Response and Survival in Rectal Cancer Patients After Neoadjuvant Chemoradiation. Anticancer Res Kim BH, Lee J, Lee D, Kim K, Kim JW, Ha B, Jang HJ, Chang MS, Shin E. PMID: 41469098 [PubMed - indexed for MEDLINE]
	Intraductal Papillary Mucinous Neoplasms (IPMN): An Overall Review and a Retrospective Analysis of 22 Patients. Anticancer Res Nardi P, Varcasia E, Rinaldi V, Pasqua R, Coletta E, Saullo P, Caronna R, Casella G, Gissey LC, Prezioso G, D'Andrea V, Angrisani M, Meniconi RL, Illuminati G, Ettorre GM. PMID: 41469095 [PubMed - indexed for MEDLINE]
	Oncological Outcomes of Laparoscopic Surgery With Stent Bridge in Stage II-III Obstructive Colorectal Cancer. Anticancer Res Matsubara D, Soga K, Fujita Y, Ochi F, Tani N, Nakagawa N, Fuji N, Okamoto K, Otsuji E, Shiozaki A. PMID: 41469093 [PubMed - indexed for MEDLINE]
	Effect of the Endoscopic Surgical Skill Qualification System for Colorectal Cancer Surgery With Multivisceral Resection on Long-term Outcomes: Japanese Multicenter Analysis. Anticancer Res Katayama H, Noda K, Tominaga T, Hashimoto S, Yamashita M, Maruta H, Tei S, Ono R, Ishii M, Oishi K, Inao A, Moriyama M, Onoda T, Shiraishi T, Kunizaki M, Nonaka T, Matsumoto K. PMID: 41469092 [PubMed - indexed for MEDLINE]
	Effect of Pathological Response After Neoadjuvant Chemotherapy on Long-term Outcomes in Locally Advanced Colorectal Cancer: A Japanese Multicenter Study. Anticancer Res Noda K, Tominaga T, Hashimoto S, Yamashita M, Maruta H, Tei S, Ono R, Ishii M, Oishi K, Inao A, Moriyama M, Onoda T, Shiraishi T, Kunizaki M, Nonaka T, Matsumoto K. PMID: 41469091 [PubMed - indexed for MEDLINE]
	Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment. Anticancer Res Ohtaki KI, Takeuchi R, Iwayama K, Chuma M, Tasaki Y, Saito Y. PMID: 41469090 [PubMed - indexed for MEDLINE]
	Automating tumor-stroma ratio quantification in colon cancer patients from the UNITED study. ESMO Open Heilijgers F, Polack M, Roodvoets AGH, Meershoek-Klein Kranenbarg E, Peeters KCMJ, Buettner R, Tolkach Y, Mesker WE, UNITED Collaboration. PMID: 41468683 [PubMed - as supplied by publisher]
	Predictive value of DWI signal and IVIM of pelvic bone marrow for hematological toxicity in rectal cancer patients undergoing concurrent chemoradiotherapy. Discov Oncol Hu L, Pan JF, Han Z, Xia XM, Zhu SJ. PMID: 41467955 [PubMed - as supplied by publisher]
	Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI). Clin Transl Radiat Oncol Raynaud C, Nebbache R, Belkacemi Y, Chargari C, Durdux C, Hennequin C, Huguet F, Quero L, Bibault JE. PMID: 41467108 [PubMed]
	Prognostic Role of Inflammatory Biomarkers in Gastrointestinal Neuroendocrine Neoplasms: A Cross-Sectional Study. Health Sci Rep Mahdavi H, Kaveh V, Ijadi Nasrabadi M, Karimi MA, Azizmohammad Looha M. PMID: 41466721 [PubMed]
	Totally Laparoscopic Versus Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Laparoendosc Adv Surg Tech A Valladão VDCS, Pasqualotto E, Delgado LM, Martins GHA, Pompeu BF. PMID: 41466521 [PubMed - as supplied by publisher]
	Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial. Trials Lalmahomed TA, Monninkhof EM, van Rijssel MJ, van Melick HHE, Verkooijen HM, de Boer JCJ, van der Voort van Zyp JRN. PMID: 41466435 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 234450

Page 1 de 11723



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité